These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 26352791)

  • 1. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
    Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
    Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
    Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
    Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis.
    Zhou S; Chen L; Mashrah M; Zhu Y; Liu J; Yang X; He Z; Wang L; Xiang T; Yao Z; Guo F; Yang W; Zhang C
    Onco Targets Ther; 2015; 8():2923-31. PubMed ID: 26508877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.
    Chan SL; Cui Y; van Hasselt A; Li H; Srivastava G; Jin H; Ng KM; Wang Y; Lee KY; Tsao GS; Zhong S; Robertson KD; Rha SY; Chan AT; Tao Q
    Lab Invest; 2007 Jul; 87(7):644-50. PubMed ID: 17384664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
    Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
    Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
    Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
    BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
    Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
    Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma.
    Yang SH; Li SL; Dong ZM; Kan QC
    Oncol Res; 2012; 20(2-3):123-30. PubMed ID: 23193918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
    Delmas AL; Riggs BM; Pardo CE; Dyer LM; Darst RP; Izumchenko EG; Monroe M; Hakam A; Kladde MP; Siegel EM; Brown KD
    Carcinogenesis; 2011 Nov; 32(11):1625-33. PubMed ID: 21873353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TUSC3, p53 and p21 genetic association with development of oral submucous fibrosis and oral squamous cell carcinoma among addictive tobacco chewers of Pakistan.
    Zaidi SAA; Chughtai N; Abbassi ZA; Alam J; Malick TS; Salim A; Saleem S
    BMC Oral Health; 2024 Jul; 24(1):780. PubMed ID: 38992585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma.
    Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T
    Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
    Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
    Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
    Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z
    Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
    Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
    J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
    Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
    Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis.
    Xu C; Zhao J; Loo WT; Hao L; Wang M; Cheung MN; Dou Y; Yip AY; Ng EL; Chow LW; Liu Q
    Int J Biol Markers; 2012 Dec; 27(4):e314-21. PubMed ID: 23250779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
    Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
    Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.